Fresenius Kabi Oncology (Delisted) share price
BSE: 532545
Fresenius Kabi Oncology Limited · Formerly Dabur Pharma · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 2004
Last traded ₹132.50 on 2 Jan 2014
Delisted on 10 Jan 2014.
Last announcements
The company's own last announcements before its shares stopped trading, routine notices left out.
Dec 2013
20 Dec · Suspension and Delisting of Trading in Equity Shares
Members of the Exchange are hereby informed that the trading in the equity shares of Fresenius Kabi Oncology Limited shall be suspended w.e.f. January 03, 2014 (i.e. w.e.f. closing hours of trading on January 02, 2014 ) on account of voluntary delisting pursuant to the SEBI (Delisting of Equity Shares) Regulations, 2009. The admission to dealings in securities of the said company shall be withdrawn (delisted) w.e.f. January 10, 2014. Further, It may be noted that SEBI has informed the Exchange vide its letter dated December 20, 2013 that they have filed an appeal in this matter in the Hon ble Supreme Court and the outcome of the same is awaited.12 Dec · Management
Dr. Patricia Grigoleit , Non-Executive Director of the Company, has resigned from the directorship of the Company with effect from December 11, 2013.11 Dec · Management
Dr. Patricia Grigoleit, Non - Executive Director of the Company, has resigned from the directorship of the Company with effect from December 11, 2013.
Results for the quarter to Sep 2013
Standalone: the listed company alone, without its subsidiaries. ₹ crore.
- RevenueRevenue from operations. Money earned from selling the company's goods and services in the period. Revenue from operations in the glossary
- ₹96 Cr−41.6% on a year ago · −24.2% on the quarter beforeChange on a year ago and on the quarter before. The change against the same quarter a year before: (this quarter's figure less that quarter's) divided by that quarter's, times 100. The change on the quarter before is the same sum against the quarter just before, taken as this quarter's results restate it where the company restated it: this quarter's year to date less this quarter. Left out where either figure is a loss, where the restatement covers two or more earlier quarters without saying which, or across a change of basis named under the table, on the lines it affects.
- Operating profitOperating profit before depreciation (EBITDA). Revenue less operating expenses: what the business earns from its operations before depreciation, interest and tax. Operating profit before depreciation (EBITDA) in the glossary
- −₹29 Cr
- Net profitNet profit. What is left of revenue and other income after every cost, interest and tax. Net profit in the glossary
- −₹45 Cr
- Earnings per shareEarnings per share. Profit belonging to shareholders divided by the number of shares, restated for later splits and bonuses so they do not break the line. Earnings per share in the glossary
- −₹2.83
- Operating margin
- −30.0%
- Net margin
- −46.6%
From revenue to net profit, ₹ crore
- Revenue96
- Operating expenses−125
- Operating profit−29
- Depreciation−7.5
- Other income0.0
- Finance costs−7.3
- Profit before tax−44
- Tax−1.1
- Net profit−45
Fresenius Kabi Oncology results by quarter
Standalone: the listed company alone, without its subsidiaries. Latest quarter to Sep 2013. Results for the quarter to Dec 2013 were due by 14 Feb 2014, 45 days after it ends. Every company's dates are on the results calendar.
Revenue and net profit by quarter, ₹ crore
- Revenue
- Net profit
- Loss
Peak revenue ₹205 Cr, quarter to Dec 2012; lowest ₹93 Cr, quarter to Mar 2013A loss in the quarter to Sep 2013, −₹45 Cr
Operating and net margin by quarter, per cent
- Operating margin
- Net margin
| ₹ crore | Dec 2008 | Mar 2009 | Jun 2009 | Sep 2009 | Dec 2009 | Mar 2010 | Jun 2010 | Sep 2010 | Dec 2010 | Mar 2011 | Jun 2011 | Sep 2011 | Dec 2011 | Mar 2012 | Jun 2012 | Sep 2012 | Dec 2012 | Mar 2013 | Jun 2013 | Sep 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 54 | 76 | 103 | 103 | 105 | – | 103 | 105 | 114 | – | 115 | 159 | 128 | 122 | 133 | 165 | 205 | 93 | 127 | 96 |
| Operating expenses. What the business spent to run itself in the period, materials, staff and other costs, before depreciation, interest and tax. Operating expenses in the glossary | 103 | 80 | 67 | 61 | 85 | – | 71 | 68 | 98 | – | 92 | 141 | 115 | 108 | 111 | 117 | 144 | 82 | 118 | 125 |
| Materials and goods boughtCost of materials and goods. Raw materials used and goods bought for resale in the period, adjusted for the change in stock held. Cost of materials and goods in the glossary | 17 | 19 | 26 | 30 | 32 | – | 34 | 30 | 44 | – | 38 | 75 | 57 | 44 | 57 | 50 | 49 | 17 | 37 | 29 |
| Operating profit before depreciation | −49 | −4 | 35 | 42 | 20 | – | 33 | 36 | 17 | – | 23 | 19 | 14 | 14 | 22 | 48 | 61 | 11 | 8 | −29 |
| Operating margin | −90.1% | −5.2% | 34.4% | 41.2% | 18.7% | – | 31.5% | 34.7% | 14.7% | – | 20.0% | 11.8% | 10.6% | 11.4% | 16.7% | 29.2% | 29.9% | 12.2% | 6.7% | −30.0% |
| Depreciation and amortisationDepreciation and amortisation. The part of the cost of plant, buildings and other long-lived assets charged against each year they are used. Depreciation and amortisation in the glossary | 3 | 3 | 3 | 8 | 3 | – | 3 | 4 | 5 | – | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 7 | 7 | 8 |
| Other incomeOther income. Income from outside the main business, such as interest on deposits, dividends received and gains on investments. Other income in the glossary | – | – | – | – | 1 | – | 1 | 1 | 1 | – | 0 | 0 | 0 | 0 | 0 | 1 | – | 1 | 1 | 0 |
| Finance costsFinance costs. Interest and the other costs of borrowing in the period. Finance costs in the glossary | 7 | 5 | 6 | 5 | 5 | – | 5 | 5 | 4 | – | 5 | 2 | 2 | 6 | 0 | 7 | −8 | −2 | −5 | 7 |
| Profit before tax | −59 | −12 | 27 | 29 | 12 | – | 25 | 29 | 10 | – | 12 | 11 | 6 | 2 | 17 | 35 | 62 | 8 | 7 | −44 |
| 4 | −3 | 4 | 7 | −1 | – | 7 | 7 | 6 | – | 2 | 3 | 2 | 3 | 4 | 8 | 14 | 9 | 2 | 1 | |
| Tax rateEffective tax rate. Tax charged as a percentage of profit before tax. Effective tax rate in the glossary | – | – | 16.7% | 23.1% | −8.7% | – | 26.7% | 24.2% | 64.4% | – | 19.4% | 27.4% | 28.1% | 141.9% | 22.2% | 22.6% | 22.4% | 112.3% | 32.5% | – |
| Net profit | −63 | −9 | 27 | 22 | 13 | – | 18 | 22 | 6 | – | 10 | 45 | 1 | 5 | 13 | 27 | 48 | −8 | 5 | −45 |
| Net margin | −116.0% | −11.3% | 26.1% | 21.5% | 12.6% | – | 17.6% | 20.9% | 5.4% | – | 8.6% | 28.5% | 1.1% | 4.0% | 9.8% | 16.4% | 23.6% | −8.3% | 3.8% | −46.6% |
| Earnings per share | −₹4.03 | −₹0.55 | ₹1.69 | ₹1.40 | ₹0.83 | – | ₹1.15 | ₹1.38 | ₹0.39 | – | ₹0.63 | ₹2.87 | ₹0.09 | ₹0.31 | ₹0.82 | – | ₹3.06 | −₹0.49 | ₹0.30 | −₹2.83 |
Earnings per share in rupees, restated for later splits and bonuses. No results on record for the quarters to Mar 2010 and Mar 2011.
The quarters either side of a change of basis do not compare. From the quarter to Mar 2009, the company's revenue for the year to Mar 2009, ₹275 Cr, differs from its quarters added, ₹299 Cr.
6 years at a glance
Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.
Revenue, net profit and borrowings, ₹ crore
- Revenue
- Net profit
- Borrowings
- Loss
A loss in 1 of the 6 years shown
Operating and net margin, per cent
- Operating marginOperating margin. Operating profit before depreciation as a percentage of revenue: how much of each rupee of sales is left after running costs. Operating margin in the glossary
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
The years either side of a change of basis do not compare. From the year to Mar 2009, the company's revenue for that year, ₹275 Cr, differs from its quarters added, ₹299 Cr.
Results for the year to Mar 2013
Standalone: the listed company alone, without its subsidiaries. ₹ crore.
From revenue to net profit
- Revenue596
- Operating expenses−453
- Operating profit143
- Depreciation−26
- Other income+1.8
- Finance costs+2.6
- Profit before tax122
- Tax−34
- Net profit81
Profit and loss
Standalone, ₹ crore, years to March. The last column is the twelve months to Sep 2013, the latest four quarters added.
| ₹ crore | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Sep 2013Twelve months |
|---|---|---|---|---|---|---|---|
| Revenue from operations | 241 | 275 | 421 | 412 | 524 | 596 | 521 |
| 215 | 304 | 325 | 316 | 457 | 453 | 469 | |
| Materials and goods bought | 60 | 98 | 119 | 135 | 215 | 161 | 133 |
| Operating profit before depreciation | 26 | −29 | 97 | 96 | 67 | 143 | 52 |
| Operating margin | 10.8% | −10.6% | 22.9% | 23.3% | 12.9% | 24.0% | 10.0% |
| Depreciation and amortisation | 5 | 12 | 13 | 17 | 24 | 26 | 28 |
| Operating profit after depreciationOperating profit after depreciation (EBIT). Operating profit before depreciation, less depreciation and amortisation. Operating profit after depreciation (EBIT) in the glossary | 21 | −41 | 84 | 79 | 43 | 117 | 25 |
| Other income | 17 | – | 6 | 6 | 1 | 2 | – |
| Finance costs | 8 | 22 | 19 | 18 | 13 | −3 | −7 |
| Profit before tax | 30 | −63 | 71 | 67 | 32 | 122 | 33 |
| 6 | 3 | 6 | 21 | 13 | 34 | 26 | |
| Net profit | 149 | −78 | 80 | 49 | 51 | 81 | 1 |
| Net margin | 62.0% | −28.2% | 19.0% | 11.9% | 9.7% | 13.5% | 0.1% |
Ratios
Standalone, years to March.
| Ratio | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 |
|---|---|---|---|---|---|---|
| Revenue growthRevenue growth. This year's revenue less last year's, divided by last year's, times 100; blank where last year's is not above nought. Revenue growth in the glossary | – | – | 53.2% | −2.2% | 27.1% | 13.7% |
| Operating profit growthOperating profit growth. This year's operating profit before depreciation less last year's, divided by last year's, times 100; blank where last year's is not above nought. Operating profit growth in the glossary | – | – | – | −0.7% | −29.7% | 112.0% |
| Net profit growthNet profit growth. This year's net profit less last year's, divided by last year's, times 100; blank where last year's is not above nought. Net profit growth in the glossary | – | – | – | −38.6% | 3.5% | 58.2% |
| Earnings per share growthEarnings per share growth. This year's earnings per share less last year's, on the same share count, divided by last year's, times 100; blank where last year's is not above nought. Earnings per share growth in the glossary | – | – | – | −38.7% | 3.5% | 58.1% |
| Interest coverInterest cover. Operating profit after depreciation divided by finance costs: how many times over the profit pays the interest bill. Interest cover in the glossary | 2.6 | – | 4.3 | 4.4 | 3.3 | −45.0 |
Interest cover is left blank for the year to Mar 2009: operating profit after depreciation is a loss, and a loss covers no interest bill. Revenue growth is left blank for the year to Mar 2009: between the two periods the company restated its earlier figures, so the two are on different bases and the change is not worked out.
Growth and returns over 3, 5 and 10 years
Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2013.
| Measure | 5 years | 3 years |
|---|---|---|
| Revenue growth, yearly rateRevenue growth, yearly rate. 3 years: Revenue in the latest year ÷ revenue in the year three years before, to the power of one third, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. 5 years: Revenue in the latest year ÷ revenue in the year five years before, to the power of one fifth, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. 10 years: Revenue in the latest year ÷ revenue in the year ten years before, to the power of one tenth, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. | – | 12.3% |
| Profit growth, yearly rateProfit growth, yearly rate. 3 years: Profit to the company's own shareholders in the latest year ÷ profit to the company's own shareholders in the year three years before, to the power of one third, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. 5 years: Profit to the company's own shareholders in the latest year ÷ profit to the company's own shareholders in the year five years before, to the power of one fifth, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. 10 years: Profit to the company's own shareholders in the latest year ÷ profit to the company's own shareholders in the year ten years before, to the power of one tenth, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. | −11.6% | 0.2% |
| Operating margin, averageOperating margin, average. 3 years: The plain average of the yearly operating profit margin over the last three years, needing at least two of them; a year without the figure is left out, never filled in. 5 years: The plain average of the yearly operating profit margin over the last five years, needing at least four of them; a year without the figure is left out, never filled in. 10 years: The plain average of the yearly operating profit margin over the last ten years, needing at least nine of them; a year without the figure is left out, never filled in. | 14.5% | 20.0% |
| Net margin, averageNet margin, average. 3 years: The plain average of the yearly net profit margin over the last three years, needing at least two of them; a year without the figure is left out, never filled in. 5 years: The plain average of the yearly net profit margin over the last five years, needing at least four of them; a year without the figure is left out, never filled in. 10 years: The plain average of the yearly net profit margin over the last ten years, needing at least nine of them; a year without the figure is left out, never filled in. | 5.2% | 11.7% |
| Interest cover, averageInterest cover, average. 3 years: The plain average of the yearly interest cover over the last three years, needing at least two of them; a year without the figure is left out, never filled in. 5 years: The plain average of the yearly interest cover over the last five years, needing at least four of them; a year without the figure is left out, never filled in. 10 years: The plain average of the yearly interest cover over the last ten years, needing at least nine of them; a year without the figure is left out, never filled in. | −8.2 | −12.4 |
Accounting checks
Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.
| Check | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 |
|---|---|---|---|---|
| Effective tax ratePublished threshold 17.16 per cent | 8.28 | 30.83 | 42.03 | 28.14 |
A threshold marked as ours has no published figure; it is the line we read the check against.
Where the return came from
Yearly rates to Mar 2013, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −29.0% | +58.1% | −55.1% | 0.0% |
| 3 years | −4.3% | +0.1% | −4.4% | 0.0% |
| 5 years | +10.8% | −11.8% | +25.6% | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add.
Recent sessions
The 10 trading days to 2 Jan 2014, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 2 Jan 2014 | 132.00 | 132.75 | 132.00 | 132.50 | 132.46 | 1,75,153 |
| 1 Jan 2014 | 131.20 | 132.50 | 131.20 | 132.05 | 132.02 | 2,02,740 |
| 31 Dec 2013 | 131.80 | 132.00 | 131.75 | 131.90 | 131.89 | 69,243 |
| 30 Dec 2013 | 131.65 | 132.00 | 131.20 | 132.00 | 131.95 | 3,80,448 |
| 27 Dec 2013 | 131.50 | 132.00 | 131.50 | 131.65 | 131.67 | 14,427 |
| 26 Dec 2013 | 132.00 | 132.00 | 131.10 | 132.00 | 131.98 | 5,31,224 |
| 24 Dec 2013 | 131.50 | 132.30 | 131.50 | 132.00 | 131.99 | 4,45,569 |
| 23 Dec 2013 | 131.50 | 132.80 | 131.10 | 132.20 | 131.77 | 39,651 |
| 20 Dec 2013 | 130.25 | 131.00 | 130.25 | 130.40 | 130.46 | 17,214 |
| 19 Dec 2013 | 131.35 | 131.35 | 130.40 | 130.55 | 130.45 | 4,217 |
Prices in ₹ per share as traded, not adjusted.
Company details
- BSE code
- 532545
- ISIN
- INE575G01010
- Former symbols
- FKONCO, DABURPHARM
- CIN
- L24231DL2003PLC119441
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 2003
- Registered office
- B-310, Som Datt Chambers - I, Bhikaji Cama Place, New Delhi 110066, Delhi
- Share registrar
- MCS Share Transfer Agent Ltd
- Keeps the register of shareholders and handles transfers and dividend payments